| Keywords: |
child; neutropenia; review; patient selection; human immunodeficiency virus infection; granulocyte macrophage colony stimulating factor; immunoglobulin; drug effect; chronic disease; autoimmunity; leukocyte count; granulocyte colony stimulating factor; granulocyte colony-stimulating factor; hiv infections; intravenous drug administration; human immunodeficiency virus 1; hemopoietic growth factor; hiv-1; immunoglobulins, intravenous; granulocyte-macrophage colony-stimulating factor; interleukin 3; human; priority journal; support, non-u.s. gov't; hematopoietic cell growth factors
|
